NCT02415439

A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects

A Phase 1 Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 86 (actual)
• Sponsor: ReveraGen BioPharma, Inc. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to examine the safety, tolerability, and PK of various increasing single and multiple doses of VBP15 in healthy adult subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	VBP15
DRUG	Placebo

Timeline

• Start date: 2015-01-01
• Primary completion: 2015-11-01
• Completion: 2016-05-01
• First posted: 2015-04-14
• Last updated: 2017-03-10
• Results posted: 2017-01-05

Locations

1 site across 1 country: United States